Epithelial ovarian cancer: Evolution of management in the era of precision medicine von Lheureux, Stephanie, Braunstein, Marsela, Oza, Amit M.

Volltext

Outcomes and endpoints in trials of cancer treatment: the past, present, and future von Wilson, Michelle K, FRACP, Karakasis, Katherine, MSc, Oza, Amit M, Prof

Volltext

Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer von McMullen, Michelle, Karakasis, Katherine, Madariaga, Ainhoa, Oza, Amit M.

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

Treatment strategies for endometrial cancer: current practice and perspective von Lee, Yeh C, Lheureux, Stephanie, Oza, Amit M

Volltext

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial von Moore, Kathleen N, Secord, Angeles Alvarez, Geller, Melissa A, Miller, David Scott, Cloven, Noelle, Fleming, Gini F, Wahner Hendrickson, Andrea E, Azodi, Masoud, DiSilvestro, Paul, Oza, Amit M, Cristea, Mihaela, Berek, Jonathan S, Chan, John K, Rimel, Bobbie J, Matei, Daniela E, Li, Yong, Sun, Kaiming, Luptakova, Katarina, Matulonis, Ursula A, Monk, Bradley J

Volltext

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial von Swisher, Elizabeth M, Dr Prof, Lin, Kevin K, PhD, Oza, Amit M, Prof, Scott, Clare L, PhD, Giordano, Heidi, MA, Sun, James, PhD, Konecny, Gottfried E, MD, Coleman, Robert L, Prof, Tinker, Anna V, MD, O'Malley, David M, MD, Kristeleit, Rebecca S, MD, Ma, Ling, MD, Bell-McGuinn, Katherine M, MD, Brenton, James D, Prof, Cragun, Janiel M, MD, Oaknin, Ana, MD, Ray-Coquard, Isabelle, Prof, Harrell, Maria I, PhD, Mann, Elaina, MS, Kaufmann, Scott H, Prof, Floquet, Anne, MD, Leary, Alexandra, MD, Harding, Thomas C, PhD, Goble, Sandra, MS, Maloney, Lara, BA, Isaacson, Jeff, PhD, Allen, Andrew R, MD, Rolfe, Lindsey, MBChB, Yelensky, Roman, PhD, Raponi, Mitch, PhD, McNeish, Iain A, Prof

Volltext

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial von Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof

Volltext

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial von Oza, Amit M, Prof, Cook, Adrian D, MSc, Pfisterer, Jacobus, Prof, Embleton, Andrew, MSc, Ledermann, Jonathan A, Prof, Pujade-Lauraine, Eric, Prof, Kristensen, Gunnar, Prof, Carey, Mark S, MD, Beale, Philip, MD, Cervantes, Andrés, Prof, Park-Simon, Tjoung-Won, Prof, Rustin, Gordon, Prof, Joly, Florence, Prof, Mirza, Mansoor R, MD, Plante, Marie, MD, Quinn, Michael, Prof, Poveda, Andrés, MD, Jayson, Gordon C, Prof, Stark, Dan, MD, Swart, Ann Marie, Prof, Farrelly, Laura, MSc, Kaplan, Richard, Prof, Parmar, Mahesh K B, Prof, Perren, Timothy J, Prof

Volltext

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma von Lin, Kevin K, Harrell, Maria I, Oza, Amit M, Oaknin, Ana, Ray-Coquard, Isabelle, Tinker, Anna V, Helman, Elena, Radke, Marc R, Say, Carmen, Vo, Lan-Thanh, Mann, Elaina, Isaacson, Jeffrey D, Maloney, Lara, O'Malley, David M, Chambers, Setsuko K, Kaufmann, Scott H, Scott, Clare L, Konecny, Gottfried E, Coleman, Robert L, Sun, James X, Giordano, Heidi, Brenton, James D, Harding, Thomas C, McNeish, Iain A, Swisher, Elizabeth M

Volltext

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression von Lheureux, Stephanie, Oaknin, Ana, Garg, Swati, Bruce, Jeffrey P., Madariaga, Ainhoa, Dhani, Neesha C., Bowering, Valerie, White, Justin, Accardi, Sarah, Tan, Qian, Braunstein, Marsela, Karakasis, Katherine, Cirlan, Iulia, Pedersen, Stephanie, Li, Tiantiam, Farinas-Madrid, Lorena, Lee, Yeh Chen, Liu, Zhihui (Amy), Pugh, Trevor J., Oza, Amit M.

Volltext

A Phase 3 Trial of Bevacizumab in Ovarian Cancer von Perren, Timothy J, Swart, Ann Marie, Pfisterer, Jacobus, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Kurzeder, Christian, Bois, Andreas du, Sehouli, Jalid, Kimmig, Rainer, Stähle, Anne, Collinson, Fiona, Essapen, Sharadah, Gourley, Charlie, Lortholary, Alain, Selle, Frédéric, Mirza, Mansoor R, Leminen, Arto, Plante, Marie, Stark, Dan, Qian, Wendi, Parmar, Mahesh K.B, Oza, Amit M

Volltext

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2) von Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L., Aghajanian, Carol, Konecny, Gottfried E., O’Malley, David M., Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-may, Wahner Hendrickson, Andrea E., Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S., Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H., Elvin, Julia A., Lin, Douglas I., Chambers, Setsuko K., Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L., Lin, Kevin K., McNeish, Iain A.

Volltext

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines von Tischkowitz, Marc, Huang, Sidong, Banerjee, Susana, Hague, Jennifer, Hendricks, William P. D., Huntsman, David G., Lang, Jessica D., Orlando, Krystal A., Oza, Amit M., Pautier, Patricia, Ray-Coquard, Isabelle, Trent, Jeffrey M., Witcher, Michael, Witkowski, Leora, McCluggage, W. Glenn, Levine, Douglas A., Foulkes, William D., Weissman, Bernard E.

Volltext

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates von Kis, Olena, Kaedbey, Rayan, Chow, Signy, Danesh, Arnavaz, Dowar, Mark, Li, Tiantian, Li, Zhihua, Liu, Jessica, Mansour, Mark, Masih-Khan, Esther, Zhang, Tong, Bratman, Scott V., Oza, Amit M., Kamel-Reid, Suzanne, Trudel, Suzanne, Pugh, Trevor J.

Volltext

Epithelial ovarian cancer von Lheureux, Stephanie, Gourley, Charlie, Vergote, Ignace, Oza, Amit M

Volltext

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial von Monk, Bradley J, Prof, Poveda, Andrés, MD, Vergote, Ignace, MD, Raspagliesi, Francesco, MD, Fujiwara, Keiichi, MD, Bae, Duk-Soo, MD, Oaknin, Ana, MD, Ray-Coquard, Isabelle, MD, Provencher, Diane M, MD, Karlan, Beth Y, MD, Lhommé, Catherine, MD, Richardson, Gary, MD, Rincón, Dolores Gallardo, MD, Coleman, Robert L, MD, Herzog, Thomas J, MD, Marth, Christian, PhD, Brize, Arija, MD, Fabbro, Michel, MD, Redondo, Andrés, MD, Bamias, Aristotelis, PhD, Tassoudji, Marjan, MS, Navale, Lynn, MS, Warner, Douglas J, MD, Oza, Amit M, MD

Volltext

Rethinking ovarian cancer: recommendations for improving outcomes von Bowtell, David D, Vaughan, Sebastian, Coward, Jermaine I, Bast, Robert C, Berchuck, Andy, Berek, Jonathan S, Brenton, James D, Coukos, George, Crum, Christopher C, Drapkin, Ronny, Etemadmoghadam, Dariush, Friedlander, Michael, Gabra, Hani, Kaye, Stan B, Lord, Chris J, Lengyel, Ernst, Levine, Douglas A, McNeish, Iain A, Menon, Usha, Mills, Gordon B, Nephew, Kenneth P, Oza, Amit M, Sood, Anil K, Stronach, Euan A, Walczak, Henning, Balkwill, Frances R

Volltext

Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing von Garg, Swati, Nagaria, Teddy S., Clarke, Blaise, Freedman, Orit, Khan, Zanobia, Schwock, Joerg, Bernardini, Marcus Q., Oza, Amit M., Han, Kathy, Smith, Adam C., Stockley, Tracy L., Rouzbahman, Marjan

Volltext

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group von OZA, Amit M, ELIT, Laurie, MACKAY, Helen J, MAZURKA, John, SEDERIAS, Joana, IVY, Percy, DANCEY, Janet E, EISENHAUER, Elizabeth A, TSAO, Ming-Sound, KAMEL-REID, Suzanne, BIAGI, Jim, PROVENCHER, Diane Michele, GOTLIEB, Walter H, HOSKINS, Paul J, GHATAGE, Prafull, TONKIN, Katia S

Volltext